Literature DB >> 31178347

Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West?

T-H So1, S-K Chan2, V H-F Lee3, B-Z Chen4, F-M Kong3, L-X Lao5.   

Abstract

Chinese medicine therapies in cancer treatment are very common in the East. Although it is usually classified as a form of complementary and alternative therapy in the West, Chinese medicine is an independent medical profession in Hong Kong and mainland China. It has a different perspective in understanding health and diseases compared with Western medicine. In oncology practice, whereas Western medicine focuses on direct tumour eradication by surgery, radiation therapy and systemic therapies, Chinese medicine focuses on restoring body balance and enhancing the body's defences (immunity), in addition to some cytotoxic herbal therapies. Most often patients, especially those in the East, receive both treatments. Chinese medicine is also commonly used to reduce side-effects from chemotherapy or radiation therapy, to aid recovery after an operation, to palliate symptoms and to address survivorship issues. However, this raises concerns of drug-herb interactions and toxicity in combination therapies. Commonly used Chinese medicine treatment modalities include acupuncture, moxibustion, diet therapy, prescribed Chinese medicine herbal decoction, single Chinese medicine herbs or supplements and tai chi. Although there is an increasing trend of Chinese medicine use in cancer patients in both the East and the West, the scientific evidence of safety and efficacy is often questioned by oncologists. This article reviews the current evidence in different Chinese medicine therapies in cancer management in both the East and the West.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer management; Chinese medicine; herbal medicine; traditional Chinese medicine

Mesh:

Year:  2019        PMID: 31178347     DOI: 10.1016/j.clon.2019.05.016

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  16 in total

1.  ATAS Acupuncture Reduces Chemotherapy Induced Fatigue in Breast Cancer Through Regulating ADROA1 Expression: A Randomized Sham-Controlled Pilot Trial.

Authors:  Yun-Fen Li; De-Quan Liu; Jian-Yun Nie; De-Dian Chen; Mei Yan; Zhen Zuo; Liang-Xian Liu; Wei-Yu Wang; Mian-Sheng Zhu; Wen-Hui Li
Journal:  Onco Targets Ther       Date:  2020-11-17       Impact factor: 4.147

2.  Why we need to pay attention to toxicity associated with herbal medicines.

Authors:  Elena Y Enioutina; Kathleen M Job; Catherine M T Sherwin
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

3.  Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Sha Li; Tsz-Him So; Guoyi Tang; Hor-Yue Tan; Ning Wang; Bacon Fung Leung Ng; Chris Kam Wa Chan; Edwin Chau-Leung Yu; Yibin Feng
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

Review 4.  Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.

Authors:  Yang Zhang; Yanni Lou; Jingbin Wang; Cunguo Yu; Wenjuan Shen
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 5.  The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Ze Peng; Wen Wen Wu; Ping Yi
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

6.  The 24-Form Tai Chi Improves Anxiety and Depression and Upregulates miR-17-92 in Coronary Heart Disease Patients After Percutaneous Coronary Intervention.

Authors:  Jia Liu; Ping Yu; Wei Lv; Xinxin Wang
Journal:  Front Physiol       Date:  2020-03-11       Impact factor: 4.566

7.  Efficacy and safety of Xiaoaiping injection for liver cancer: A protocol for systematic review and meta-analysis.

Authors:  Daorui Hou; Jian Xiong; Ya Li; Yahui Peng; Lu Xiong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

8.  Efficacy and safety of Xiaoaiping injection for breast cancer: A protocol for systematic review and meta-analysis.

Authors:  Daorui Hou; Jian Xiong; Yahui Peng; Ya Li; Lu Xiong
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

9.  Efficacy and safety of Brucea javanica oil emulsion for liver cancer: A protocol for systematic review and meta-analysis.

Authors:  Didi Luo; Daorui Hou; Tiancheng Wen; Meiling Feng; Haiming Zhang
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

10.  The efficacy and safety of moxibustion for chemotherapy-induced gastrointestinal adverse reaction: A protocol for systematic review and meta-analysis.

Authors:  Han-Xiao Zhang; Cheng-Shun Zhang; Xiao-Qin Dai; Chuan-Yi Zuo; Peng Lv; Rui-Zhen Huang; Qian-Ning Mo; Yi-Feng Bai; Yi Zhou
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.